Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin in Elective PCI to Prevent Contrast-Induced Nephropathy
NCT02737319Phase 4Completed
- Sponsor
- Universidade de São Paulo
- Start
- Mar 2011
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in contrast-induced nephropathy (CIN), sponsored by Universidade de São Paulo. Started Mar 2011; status: completed.
02
Drugs
rosuvastatin
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT02737319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02737319.